Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3′-deoxy-3′-¹⁸F-fluorothymidine PET

Keyphrases

• Antiproliferative Activity 100%
• 18F-fluorothymidine 100%
• Kinase Inhibitor Therapy 100%
• Tumor 20%
• 18F-fluorodeoxyglucose (18F-FDG) 20%
• Tumor Cell Proliferation 20%
• Kinase Inhibitor 20%
• ErbB Kinase 20%
• High-resolution 10%
• Clinical Trials 10%
• FDG Uptake 10%
• Overexpressing 10%
• Small Animal 10%
• Xenograft Tumor 10%
• Kinase Activity 10%
• Tumor Proliferation 10%
• Drug Exposure 10%
• Xenograft 10%
• Tyrosine Kinase Inhibitor 10%
• ErbB 10%
• Kinase Inhibition 10%
• Proliferation Index 10%
• ErbB1 10%
• Selective Kinase Inhibitor 10%
• Proliferating Cell nuclear Antigen 10%
• In(III) 10%
• A431 Xenograft 10%
• Baseline Signal 10%

Medicine and Dentistry

• Fluorine-18 100%
• Phosphotransferase Inhibitor 100%
• Polyethylene Terephthalate 100%
• Fluorodeoxyglucose F 18 30%
• ErbB 30%
• Neoplasm 20%
• Cell Proliferation 20%
• Tumor Cell 20%
• Phosphotransferase 20%
• Immunohistochemistry 10%
• Clinical Trial 10%
• Tumor Progression 10%
• Tumor Xenograft 10%
• Xenograft 10%
• Epidermal Growth Factor Receptor 10%
• Tyrosine-Kinase Inhibitor 10%
• Antiproliferative Activity 10%
• Proliferating Cell Nuclear Antigen 10%
• Drug Exposure 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Fluorine 18 100%
• Phosphotransferase Inhibitor 100%
• Polyethylene Terephthalate 100%
• Neoplasm 40%
• Fluorodeoxyglucose F 18 30%
• Phosphotransferase 20%
• Clinical Trial 10%
• Tumor Growth 10%
• Cycline 10%
• Protein Tyrosine Kinase Inhibitor 10%
• Epidermal Growth Factor Receptor 10%